FindTrial
Sign In

To Compare the Neurophil - Lymphocyte ratio and Serum Albumin levels in a patient of Acute Ischemic Stroke.

Neurophil - Lymphocyte ratio and Serum Albumin levels in a patient of Acute Ischemic Stroke a comparitive study. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072958
Enrollment
80
Registered
2024-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I672- Cerebral atherosclerosis Health Condition 2: I635- Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

Interventions

Intervention1: Computrized Tomography of Brain, Serum Albumin,Diffential Leucocytic count: 3 months

Sponsors

NONE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients Who Were Diagnosed With Acute Ischemic Stroke Based On Clinical (WHO Specified) As Well As Radiological Criteria At AVBRH, Sawangi.

Exclusion criteria

Exclusion criteria: Patients Diagnosed With Acute Haemorrhagic Stroke (Haemorrhagic Transformation Of Acute Ischemic Stroke Was Not Considered As Exclusion Criteria), With Prior History Of Infection Within 2 Weeks Before Stroke, With Haematological Disorders And Blood Transfusion In The Last 2 -3 Weeks, With A History Of Malignancy(Ies) And Immunosuppressant Drugs

Design outcomes

Primary

MeasureTime frame
Neutrophil Lymphocyte Ratio and Serum Albumin as a prognostic marker and Correlation of these markers. Timepoint: 2 years—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactRajesh Sarode

Datta Meghe Institute Of Higher Education

avinashparepalli@gmail.com8498848110

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026